Canada markets closed

  • S&P/TSX
    19,507.05
    +32.40(+0.17%)

  • S&P 500
    4,127.83
    -35.46(-0.85%)

  • DOW
    34,060.66
    -267.13(-0.78%)

ImmunoPrecise Antibodies Ltd. (IPA.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
9.04-0.05 (-0.55%)
At close: 3:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-04-30
2019-04-30
2018-04-30
Total Revenue
17,181
14,058
10,926
5,441
Cost of Revenue
6,476
6,024
5,632
2,990
Gross Profit
10,705
8,034
5,295
2,451
Operating Expenses
Research Development
1,138
446.28
485.845
509.248
Selling General and Administrative
12,114
8,981
9,119
6,446
Total Operating Expenses
13,800
12,081
11,520
7,212
Operating Income or Loss
-3,095
-4,047
-6,225
-4,761
Interest Expense
561.546
536.499
413.59
50.591
Total Other Income/Expenses Net
-557.019
-982.047
-1,004
-323.182
Income Before Tax
-3,468
-5,293
-7,613
-5,061
Income Tax Expense
-214.983
-345.728
4.788
109.715
Income from Continuing Operations
-3,253
-4,947
-7,617
-5,171
Net Income
-3,253
-4,947
-7,617
-5,171
Net Income available to common shareholders
-3,253
-4,947
-7,617
-5,171
Basic EPS
-
-0.35
-0.60
-0.55
Diluted EPS
-
-0.35
-0.60
-0.55
Basic Average Shares
-
13,629
12,542
9,107
Diluted Average Shares
-
13,629
12,542
9,107
EBITDA
-
-1,348
-4,936
-4,553